191731-16-5

Basic information

• Product Name: tert-Butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate
• Synonyms: tert-Butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate;(S)-TERT-BUTYL 4-(((BENZYLOXY)CARBONYL)AMINO)-5-METHYL-3-OXOHEXANOATE
• CAS NO: 191731-16-5
• Molecular Formula: C₁₉H₂₇NO₅
• Molecular Weight: 349
• Mol File: 191731-16-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 464.4°C at 760 mmHg
• Flash Point: 234.6°C
• Appearance: /
• Density: 1.1g/cm³
• Vapor Pressure: 8.41E-09mmHg at 25°C
• Refractive Index: 1.502
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-Butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate(191731-16-5)
• EPA Substance Registry System: tert-Butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate(191731-16-5)

Safety Data

• Hazardous Substances Data: 191731-16-5(Hazardous Substances Data)

Usage

General Description

Tert-butyl (S)-4-(Cbz-amino)-5-methyl-3-oxohexanoate is a chemical compound often used in organic synthesis and pharmaceutical research. It is a derivative of (S)-amino acid and is commonly referred to as a tert-butyl ester. It is known for its ability to efficiently protect amino groups in peptide synthesis and other organic reactions. The compound is typically used as a reagent in the production of peptide-based drugs and as a building block for various pharmaceuticals. Additionally, it is often utilized in the development of new synthetic methods and in the preparation of reference standards for analytical testing.

InChI:InChI=1/C19H27NO5/c1-13(2)17(15(21)11-16(22)25-19(3,4)5)20-18(23)24-12-14-9-7-6-8-10-14/h6-10,13,17H,11-12H2,1-5H3,(H,20,23)/t17-/m0/s1

Upstream product

• 1149-26-4 (S)-N-(benzyloxycarbonyl)valine 
• 1207973-75-8 lithium tert-butyl acetate 
• 540-88-5 acetic acid tert-butyl ester 
• 24210-19-3 methyl (2S)-3-methyl-[(benzyloxy)carbonylamino]butanoate 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 202806-77-7 t-butyl-(3R,4S)-4-(N-benzyloxycarbonylamino)-3-hydroxy-5-methyl-hexanoate 
• 328273-06-9 C₁₆H₂₂FNO₃ 
• 799270-24-9 (S,E)-ethyl 4-((2R,5S)-5-(tert-butoxycarbonylamino)-2-(4-fluorobenzyl)-6-methyl-4-oxoheptanamido)-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoate 
• 362610-31-9 (3-bromo-1-(S)-(1-methylethyl)-2-oxopropyl)carbamic acid benzyl ester 
• 151011-85-7 (2R,5S)-2-Benzyl-5-tert-butoxycarbonylamino-6-methyl-4-oxo-heptanoic acid 
• 223526-67-8 (2R,5S)-5-(tert-butoxycarbonylamino)-2-(4-fluorobenzyl)-6-methyl-4-oxoheptanic acid 

Relevant articles and documents

Improved synthesis of rupintrivir

An improved synthesis of rupintrivir (AG7088) was accomplished using three amino acids (l-glutamic acid, d-4-fluorophenylalanine, and l-valine) as the building blocks. The key fragment ketomethylene dipeptide isostere was constructed with the valine derivative and phenylpropionic acid derivative, followed by coupling with a lactam derivative and an isoxazole acid chloride to provide AG7088 totally in eight steps.

An efficient synthesis of γ-amino β-ketoester by cross-Claisen condensation with α-amino acid derivatives

Cross-ester condensation between N-protected amino acid ester and the lithium enolate prepared from alkyl acetate gave the corresponding β-ketoester in high yield without the formation of the tertiary alcohol that is commonly seen as by-product. This inte

Pentapeptides as antitumor agents

The present invention provides anti-tumor peptides of Formula I, and the acid salts thereof. A is an amino acid residue of the formula (CH3)2 N--CHX--CO, wherein X is a normal or branched alkyl group. B is an amino acid residue s